Table of Contents
Pictured: CHPA President & CEO Scott Melville & representatives from Bayer, Sanofi Consumer Healthcare, Haleon, & Kenvue. Photo by: Jenifer Morris Photography.
WASHINGTON – Representatives from the Consumer Healthcare Products Association (CHPA), Sanofi Consumer Healthcare, Haleon, Kenvue, and Bayer participated in a discussion this week hosted by U.S. Rep. Bob Latta (OH-05) to provide an analysis of the over-the-counter (OTC) Monograph Drug User Fee Program (OMUFA), how some OTCs come to market through the Rx-to-OTC-switch process, how these products are regulated by the U.S. Food and Drug Administration (FDA), and industry’s efforts to expand HSA/FSA coverage for dietary supplements and oral care products.
The briefing – “OTC 101” – was held on Tuesday in the U.S. Capitol and was designed to provide congressional staff with an overview of the value that self-care plays in public health, and how self-care can provide American consumers and the entire U.S. healthcare system billions in annual cost-savings. Presenters also discussed the policies and regulations that have helped the self-care industry make tremendous contributions on behalf of America’s consumers and the industry’s current legislative priorities. Speakers included: congressional self-care champion and U.S. Rep. Bob Latta (OH-05), CHPA President and CEO Scott Melville, Sanofi Consumer Healthcare Head of Public Affairs & Policy MaryAnne Dunlap, Haleon Head of U.S. Federal Affairs Jonathan Martinez, Kenvue Director of Federal Affairs Roberto Sada, and Bayer Director of Federal Relations & Policy Lindsay Morris.
“A huge thank you to our host, Congressman Bob Latta, for bringing this group together to discuss the issues that are at the forefront of the self-care industry and for his longstanding leadership and support,” said President and CEO Scott Melville. “I would like to send another special thank you to the representatives from our congressional self-care champion offices who attended this week’s event and highlight their fierce leadership on the healthcare issues that are important to CHPA, our members, and consumers. Finally, I would like to recognize the representatives from CHPA’s member companies for the work they do each day to remind Members of Congress and their staff about our industry’s commitment to ensuring all Americans have access to safe and beneficial self-care products they can count on to be reliable, save money and time, and deliver new and better ways to get and stay healthy.“
